Altre lingue Hangzhou Tigermed Consulting Co., Ltd Hong Kong S.E.

Azioni

3347

CNE1000040M1

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:17 17/05/2024			Variaz. 5gg	Var. 1 gen.
35,1 ^HKD	-3,44%		-3,70%	-0,71%

25/04	Utile di Hangzhou Tigermed Consulting in calo del 59% nel 1° trimestre	MT
25/04	Hangzhou Tigermed Consulting Co., Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 30 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	25/04
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	25/04
Tigermed Consulting's Profit, Revenue Climb in 2023	29/03
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024	28/03
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes	21/03
China Healthcare Stocks Rally on Hopes for Government Support	14/03
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares	14/03
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%	07/02
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.	06/02
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.	06/02
Hangzhou Tigermed Consulting's Profit Up 19% in Q3	27/10/23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Tigermed Reports 2023 Interim Results	28/08/23
Tigermed Consulting's Profit Jumps 16.5% in H1	28/08/23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Tigermed Officially Opens International Headquarters in Hong Kong	17/08/23
Bioclub announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd	07/08/23
Hangzhou Tigermed Consulting Co., Ltd. Announces Final Profit Distribution Plan Implementation (A Shares) for 2022, Payable on 07 July 2023	04/07/23
Hangzhou Tigermed Consulting Co. Ltd. Proposes Ordinary Final Dividend for the Year Ended December 31, 2022, Payable on 07 July 2023	26/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hangzhou Tigermed Consulting Co., Ltd Hong Kong S.E.

Azioni

3347

CNE1000040M1

Altre lingue

Filtri